495 related articles for article (PubMed ID: 25113628)
1. Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.
Royce SG; Lim CX; Patel KP; Wang B; Samuel CS; Tang ML
Clin Exp Allergy; 2014 Nov; 44(11):1399-408. PubMed ID: 25113628
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease.
Royce SG; Sedjahtera A; Samuel CS; Tang ML
Clin Sci (Lond); 2013 Jan; 124(1):41-51. PubMed ID: 22817662
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease.
Royce SG; Rele S; Broughton BRS; Kelly K; Samuel CS
FASEB J; 2017 Sep; 31(9):4168-4178. PubMed ID: 28626025
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease.
Royce SG; Shen M; Patel KP; Huuskes BM; Ricardo SD; Samuel CS
Stem Cell Res; 2015 Nov; 15(3):495-505. PubMed ID: 26426509
[TBL] [Abstract][Full Text] [Related]
5. Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease.
Royce SG; Tominaga AM; Shen M; Patel KP; Huuskes BM; Lim R; Ricardo SD; Samuel CS
Clin Sci (Lond); 2016 Dec; 130(23):2151-2165. PubMed ID: 27647937
[TBL] [Abstract][Full Text] [Related]
6. Relaxin plays an important role in the regulation of airway structure and function.
Samuel CS; Royce SG; Burton MD; Zhao C; Tregear GW; Tang ML
Endocrinology; 2007 Sep; 148(9):4259-66. PubMed ID: 17584966
[TBL] [Abstract][Full Text] [Related]
7. Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma.
Moerch U; Haahr Hansen M; Vest Hansen NJ; Rasmussen LK; Oleksiewicz MB; Frandsen TP; Haurum JS; Bregenholt S
Int Arch Allergy Immunol; 2006; 140(3):261-9. PubMed ID: 16699287
[TBL] [Abstract][Full Text] [Related]
8. Effect of roflumilast on airway remodelling in a murine model of chronic asthma.
Kim SW; Kim JH; Park CK; Kim TJ; Lee SY; Kim YK; Kwon SS; Rhee CK; Yoon HK
Clin Exp Allergy; 2016 May; 46(5):754-63. PubMed ID: 26542330
[TBL] [Abstract][Full Text] [Related]
9. Relaxin reverses airway remodeling and airway dysfunction in allergic airways disease.
Royce SG; Miao YR; Lee M; Samuel CS; Tregear GW; Tang ML
Endocrinology; 2009 Jun; 150(6):2692-9. PubMed ID: 19213838
[TBL] [Abstract][Full Text] [Related]
10. Parabromophenacyl bromide inhibits subepithelial fibrosis by reducing TGF-β1 in a chronic mouse model of allergic asthma.
Ram A; Mabalirajan U; Jaiswal A; Rehman R; Singh VP; Ghosh B
Int Arch Allergy Immunol; 2015; 167(2):110-8. PubMed ID: 26303861
[TBL] [Abstract][Full Text] [Related]
11. Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease.
Royce SG; Patel KP; Mao W; Zhu D; Lim R; Samuel CS
Br J Pharmacol; 2019 Jul; 176(13):2195-2208. PubMed ID: 30883698
[TBL] [Abstract][Full Text] [Related]
12. Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease.
Mookerjee I; Solly NR; Royce SG; Tregear GW; Samuel CS; Tang ML
Endocrinology; 2006 Feb; 147(2):754-61. PubMed ID: 16254028
[TBL] [Abstract][Full Text] [Related]
13. Trefoil factor-2 reverses airway remodeling changes in allergic airways disease.
Royce SG; Lim C; Muljadi RC; Samuel CS; Ververis K; Karagiannis TC; Giraud AS; Tang ML
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):135-44. PubMed ID: 22652198
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma.
Royce SG; Patel KP; Samuel CS
Lab Invest; 2014 Dec; 94(12):1326-39. PubMed ID: 25264707
[TBL] [Abstract][Full Text] [Related]
15. The activin A antagonist follistatin inhibits asthmatic airway remodelling.
Hardy CL; Nguyen HA; Mohamud R; Yao J; Oh DY; Plebanski M; Loveland KL; Harrison CA; Rolland JM; O'Hehir RE
Thorax; 2013 Jan; 68(1):9-18. PubMed ID: 23051972
[TBL] [Abstract][Full Text] [Related]
16. Effects of furosemide on allergic asthmatic responses in mice.
Wang S; Xiang YY; Ellis R; Wattie J; Feng M; Inman MD; Lu WY
Clin Exp Allergy; 2011 Oct; 41(10):1456-67. PubMed ID: 21729180
[TBL] [Abstract][Full Text] [Related]
17. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice.
Yamabayashi C; Koya T; Kagamu H; Kawakami H; Kimura Y; Furukawa T; Sakagami T; Hasegawa T; Sakai Y; Matsumoto K; Nakayama M; Gelfand EW; Suzuki E; Narita I
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):170-7. PubMed ID: 22403804
[TBL] [Abstract][Full Text] [Related]
18. Sites of allergic airway smooth muscle remodeling and hyperresponsiveness are not associated in the rat.
Siddiqui S; Jo T; Tamaoka M; Shalaby KH; Ghezzo H; Bernabeu M; Martin JG
J Appl Physiol (1985); 2010 Oct; 109(4):1170-8. PubMed ID: 20651225
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the respiratory sensitization potential of proteins using an enhanced mouse intranasal test (MINT).
Krieger SM; Boverhof DR; Woolhiser MR; Hotchkiss JA
Food Chem Toxicol; 2013 Sep; 59():165-76. PubMed ID: 23747714
[TBL] [Abstract][Full Text] [Related]
20. Functional inhibition of PAR2 alleviates allergen-induced airway hyperresponsiveness and inflammation.
Asaduzzaman M; Nadeem A; Arizmendi N; Davidson C; Nichols HL; Abel M; Ionescu LI; Puttagunta L; Thebaud B; Gordon J; DeFea K; Hollenberg MD; Vliagoftis H
Clin Exp Allergy; 2015 Dec; 45(12):1844-55. PubMed ID: 26312432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
